NCT00399074 Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia Status COMPLETED Phase PHASE3
NCT00393679 Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children Status COMPLETED Phase PHASE3
NCT00386763 Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria. Status COMPLETED Phase PHASE3
NCT00386750 Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function Status TERMINATED Phase PHASE4
NCT00386503 Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions Status COMPLETED Phase PHASE1
NCT00385047 A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults Status COMPLETED Phase PHASE1/PHASE2
NCT00380393 Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children. Status COMPLETED Phase PHASE2
NCT00380146 Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant Women Status COMPLETED Phase NA
NCT00378625 Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in Colombia Status COMPLETED Phase PHASE3
NCT00374998 Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP Status COMPLETED Phase PHASE1
NCT00373607 Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru Status COMPLETED Phase PHASE3
NCT00367653 Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria. Status COMPLETED Phase PHASE3
NCT00367380 Evaluation of Reproducibility of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers Status COMPLETED Phase PHASE2
NCT00361114 IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria. Status TERMINATED Phase PHASE3